Skip to main content
Trending storyHistorical stories

Bioliberty adds €2.95M Series A extension for home rehab robots

1 reports1 report sources11 days agoUpdate

Get up to speed on this story

AI Summary

Bioliberty, an Edinburgh- and Boston-based rehabilitation robotics startup, raised a €2.95M ($3.3M) Series A extension, bringing total funding to €12.07M ($13.5M). The round adds four institutional backers: TGH Ventures, Ballad Ventures, Whiterock and 25m Health. The company says its Lifehub and Lifeglov devices are FDA-listed in the US, where Bioliberty began selling commercially in 2025. The new money is aimed at bringing AI-assisted rehabilitation into patients' homes.

AI-generated from reports · 9 days agoUpdate

Report timeline

Follow the reports to understand different sides of the story.

Nov 6
  1. EU-Startups
    Bioliberty raises €2.95M Series A extension to bring AI rehabilitation into the home

    Bioliberty, an Edinburgh- and Boston-based rehabilitation robotics startup, raised a €2.95M ($3.3M) Series A extension.

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing